Publications: Dr Ruth Dobson
Dobson R, Jacobs B, Marshall C
(
2023
)
.
Polygenic risk score prediction of Multiple Sclerosis in individuals of South Asian ancestry
.
Brain Communications
Dobson R
(
2023
)
.
Menopause in women with multiple sclerosis: clinical symptoms, therapeutic considerations and possible impact on the course of the disease
.
British Journal of Neuroscience Nursing
Dobson R
(
2023
)
.
Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis (MS) during pregnancy and breastfeeding: a systematic review and Delphi consensus
.
Multiple Sclerosis Journal
Iyer P, Dobson R
(
2023
)
.
Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies
.
Neurology and Therapy
vol.
12
,
(
1
)
1
-
10
.
Kuri A, Vickaryous N, Awad A, Jacobs BM, Dobson R
(
2023
)
.
Vitamin D genetic risk scores in multiple sclerosis
.
Journal of Neurology
vol.
270
,
(
2
)
1030
-
1035
.
Teelucksingh S, Govind RM, Dobson R, Ovadia C, Nelson-Piercy C
(
2023
)
.
Treating Vestibular Migraine When Pregnant and Postpartum: Progress, Challenges and Innovations
.
International Journal of Women's Health
vol.
15
,
321
-
338
.
Noyce A
(
2022
)
.
The association between anti-epileptic drugs and incident Parkinson’s disease in UK Biobank
.
JAMA Neurology
Dreyer-Alster S, Achiron A, Giovannoni G, Jacobs BM, Dobson R
(
2022
)
.
No evidence for an association between alcohol consumption and Multiple Sclerosis risk: a UK Biobank study
.
Scientific Reports
vol.
12
,
(
1
)
Dobson R
(
2022
)
.
Social determinants of health and their impact in multiple sclerosis
.
Nature Reviews Neurology
Simpson-Yap S, Pirmani A, Kalincik T, De Brouwer E, Geys L, Parciak T, Helme A, Rijke N et al.
(
2022
)
.
Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity
.
Neurology(R) neuroimmunology & neuroinflammation
vol.
9
,
(
6
)
Dobson R, Bove R
(
2022
)
.
In Vitro Fertilization and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk
.
Neurology
vol.
99
,
(
17
)
737
-
738
.
Dobson R, Bove R
(
2022
)
.
In Vitro Fertilization and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk
.
Neurology
vol.
99
,
(
17
)
737
-
738
.
Simpson-Yap S, Pirmani A, De Brouwer E, Peeters LM, Geys L, Parciak T, Helme A, Hillert J et al.
(
2022
)
.
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β
.
Multiple Sclerosis and Related Disorders
vol.
66
,
Jacobs BM, Peter M, Giovannoni G, Noyce AJ, Morris HR, Dobson R
(
2022
)
.
Towards a global view of multiple sclerosis genetics
.
Nature Reviews Neurology
vol.
18
,
(
10
)
613
-
623
.
Hone L, Jacobs BM, Marshall C, Giovannoni G, Noyce A, Dobson R
(
2022
)
.
Age-specific effects of childhood body mass index on multiple sclerosis risk
.
Journal of Neurology
vol.
269
,
(
9
)
5052
-
5060
.
Allen-Philbey K, Stennett A, Begum T, Johnson AC, MacDougall A, Green S, Dobson R, Giovannoni G et al.
(
2022
)
.
Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis
.
Multiple Sclerosis and Related Disorders
vol.
65
,
Foote IF, Jacobs BM, Mathlin G, Watson CJ, Bothongo PL, Waters S, Dobson R, Noyce AJ et al.
(
2022
)
.
The shared genetic architecture of modifiable risk for Alzheimer's disease: a genomic structural equation modelling study
.
Neurobiology of Aging
vol.
117
,
222
-
235
.
Bove R, Hellwig K, Pasquarelli N, Borriello F, Dobson R, Oreja-Guevara C, Lin CJ, Zecevic D et al.
(
2022
)
.
Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants
.
Multiple Sclerosis and Related Disorders
vol.
64
,
Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N et al.
(
2022
)
.
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
.
Multiple Sclerosis and Related Disorders
vol.
64
,
Tur C, Dubessy AL, Otero-Romero S, Amato MP, Derfuss T, Di Pauli F, Iacobaeus E, Mycko M et al.
(
2022
)
.
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
.
Multiple Sclerosis Journal
vol.
28
,
(
9
)
1424
-
1456
.
Dobson R, Tanasescu R, Gran B
(
2022
)
.
Editorial: Preventing multiple sclerosis
.
Frontiers in Neurology
vol.
13
,
Dobson R, Rog D, Ovadia C, Murray K, Hughes S, Ford HL, Pearson OR, White S et al.
(
2022
)
.
Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines
.
Practical Neurology
vol.
23
,
(
1
)
6
-
14
.
Dobson R
(
2022
)
.
Preventing Multiple Sclerosis - from evidence to action
.
Frontiers in Neurology
Rivas C, Anand K, Wu AFW, Goff L, Dobson R, Eccles J, Ball E, Kumar S et al.
(
2022
)
.
Lessons From the COVID-19 Pandemic to Improve the Health, Social Care, and Well-being of Minoritized Ethnic Groups With Chronic Conditions or Impairments: Protocol for a Mixed Methods Study
.
JMIR Research Protocols
vol.
11
,
(
7
)
Judge-Clayden F, Iyer P, Williams A, Murray K, Dobson R
(
2022
)
.
Multiple sclerosis, disease modifying therapies and pregnancy
.
British Journal of Neuroscience Nursing
vol.
18
,
(
Sup3
)
s22
-
s26
.
Jensen M, Jacobs B, Dobson R, Bandres-Ciga S, Blauwendraat C, Schrag A, Noyce A
(
2022
)
.
Lower lymphocyte count is associated with increased risk of Parkinson’s disease
.
Journal of Neurology Neurosurgery & Psychiatry
vol.
93
,
(
6
)
a94.3
-
a9a95
.
Belete D, Jacobs BM, Bestwick JP, Dobson R, Hardy J, Giovannoni G, Lees A, Schrag A et al.
(
2022
)
.
Parkinson’s disease determinants, prediction and gene-environment interac- tions: a UK Biobank study
.
Journal of Neurology Neurosurgery & Psychiatry
vol.
93
,
(
6
)
a7.3
-
a7a8
.
Dobson R
(
2022
)
.
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)
.
Multiple Sclerosis and Related Disorders
Baker D, MacDougall A, Kang AS, Schmierer K, Giovannoni G, Dobson R
(
2022
)
.
Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?
.
Clin Exp Immunol
vol.
207
,
(
3
)
263
-
271
.
Simonet C, Bestwick J, Jitlal M, Waters S, Ben-Joseph A, Marshall CR, Dobson R, Marrium S et al.
(
2022
)
.
Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population
.
JAMA Neurology
vol.
79
,
(
4
)
359
-
369
.
Marshall CR, Noyce AJ, Neligan A, Dobson R
(
2022
)
.
Brain health: The hidden casualty of a humanitarian crisis
.
The Lancet Regional Health - Europe
vol.
15
,
Bothongo PLK, Jitlal M, Parry E, Waters S, Foote IF, Watson CJ, Cuzick J, Giovannoni G et al.
(
2022
)
.
Dementia risk in a diverse population: A single-region nested case-control study in the East End of London
.
The Lancet Regional Health - Europe
vol.
15
,
Vukusic S, Dobson R, Bove RM, Hellwig K, Pasquarelli N, Zecevic D, Oreja-Guevara C
(
2022
)
.
Données de grossesses chez des femmes recevant de l’ocrelizumab pour le traitement de la sclérose en plaques
.
Revue Neurologique
vol.
178
,
Dobson R
(
2022
)
.
Peripartum disease activity in moderately and severely disabled women with multiple sclerosis
.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
Dobson R
(
2022
)
.
Challenges and Opportunities of Real-World Data: Statistical Analysis Plan for the Optimise:MS Multicenter Prospective Cohort Pharmacovigilance Study
.
Frontiers in Neurology
Noyce A
(
2022
)
.
No evidence for association between polygenic risk of Multiple Sclerosis and MRI phenotypes in ~30,000 healthy adult UK Biobank participants
.
Multiple Sclerosis Journal
Baker D, MacDougall A, Kang AS, Schmierer K, Giovannoni G, Dobson R
(
2022
)
.
Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?
.
Clinical and Experimental Immunology
vol.
207
,
(
3
)
263
-
271
.
Hone L, Giovannoni G, Dobson R, Jacobs BM
(
2022
)
.
Predicting Multiple Sclerosis: Challenges and Opportunities
.
Frontiers in Neurology
vol.
12
,
Dobson R, Chung K
(
2022
)
.
Natalizumab concentrations during pregnancy in three patients with multiple sclerosis: A clinical commentary
.
Multiple Sclerosis Journal
vol.
28
,
(
2
)
326
-
327
.
Huxford B, Haque T, Joseph AB, Simonet C, Gallagher D, Budu C, Dobson R, Noyce AJ
(
2022
)
.
Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity
.
Movement Disorders
vol.
37
,
(
2
)
427
-
428
.
Dobson R, Marshall C, Noyce A
(
2022
)
.
Social determinants of neurological disease: tackling inequalities
.
The Lancet Neurology
vol.
21
,
(
2
)
122
-
123
.
Satukijchai C, Mariano R, Messina S, Sa M, Woodhall MR, Robertson NP, Ming L, Wassmer E et al.
(
2022
)
.
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom
.
JAMA Netw Open
vol.
5
,
(
1
)
Hartmann M, Fenton N, Dobson R
(
2022
)
.
Development of Bayesian Network for Multiple Sclerosis Risk Factor Interaction Analysis
.
vol.
13483 LNBI
,
Camera V, Messina S, Elhadd KT, Sanpera-Iglesias J, Mariano R, Hacohen Y, Dobson R, Meletti S et al.
(
2022
)
.
Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders
.
Journal of neurology, neurosurgery, and psychiatry
vol.
93
,
(
1
)
101
-
111
.
Baker D
(
2021
)
.
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis
.
Multiple Sclerosis and Related Disorders
Dobson R, Craner M, Waddingham E, Miller A, Cavey A, Webb S, Hemingway C, Hobart J et al.
(
2021
)
.
Optimise: MS study protocol: A pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis
.
BMJ Open
vol.
11
,
(
11
)
Geys L, Parciak T, Pirmani A, McBurney R, Schmidt H, Malbaša T, Ziemssen T, Bergmann A et al.
(
2021
)
.
The Multiple Sclerosis Data Alliance Catalogue Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources
.
International Journal of MS Care
vol.
23
,
(
6
)
261
-
268
.
Dobson R, Baker D, Kang A, Schmierer K, Giovannoni G
(
2021
)
.
COVID-19 vaccine response in people with multiple sclerosis
.
Annals of Neurology
Hone L, Jacobs B, Noyce A, Dobson R
(
2021
)
.
Age-specific effects of childhood BMI on multiple sclerosis risk: a Mendelian Randomisation study
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
27
,
764
-
765
.
Stennett A, Allen-Philbey K, Begum T, Johnson A, Dobson R, Giovannoni G, Gnanapavan S, Marta M et al.
(
2021
)
.
An evaluation of remote monitoring in people with MS during the COVID-19 pandemic
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
27
,
268
-
269
.
Bove R, Pasquarelli N, Borriello F, Dobson R, Hellwig K, McElrath T, Oreja-Guevara C, Wei W et al.
(
2021
)
.
B-cell levels and immunity in breastfed infants of women with MS treated with ocrelizumab: design of a phase 4 study (SOPRANINO)
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
27
,
583
-
584
.
Dobson R, Bove R, Borriello F, Craveiro L, Ferreira G, Hellwig K, McElrath T, Pasquarelli N et al.
(
2021
)
.
Pregnancy and infant outcomes in women receiving ocrelizumab for the treatment of multiple sclerosis
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
27
,
554
-
555
.
Ostrem B, Anderson A, Conway S, Oh J, Sadovnick D, Dobson R, Graham E, Jacobs D et al.
(
2021
)
.
Pregnancy outcomes and peripartum disease activity in moderately and severely disabled women with MS
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
27
,
246
-
247
.
Hellwig K, Pasquarelli N, Borriello F, Bove R, Dobson R, Oreja-Guevara C, Vukusic S, Wei W et al.
(
2021
)
.
Rationale and design of a phase 4 study exploring B-cell levels and immune responses in infants born to women with MS who were exposed to ocrelizumab up to 6 months before or during the first trimester of pregnancy (the MINORE study)
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
27
,
564
-
565
.
Vickaryous N, Asardag AN, Chance R, Jones M, Bestwick J, Shah SN, George K, Schmierer K et al.
(
2021
)
.
Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy
.
MULTIPLE SCLEROSIS JOURNAL
vol.
27
,
(
2_SUPPL
)
775
-
776
.
Simpson-Yap S, Pirmani A, De Brouwer E, Geys L, Parciak T, Helme A, Rijke N, Kalincik T et al.
(
2021
)
.
Updated results of the COVID-19 in MS global data sharing initiative validate consistent associations of anti-CD20 and other reported risk factors with severe COVID-19 outcomes
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
27
,
741
-
743
.
Hartmann M, Fenton N, Dobson R
(
2021
)
.
Using Bayesian networks to understand multiple sclerosis risk factor interactions
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
27
,
375
-
375
.
Foote I, Jacobs B, Watson C, Bothongo P, Waters S, Dobson R, Noyce A, Bhui K et al.
(
2021
)
.
W26. A MULTIVARIATE GENOME-WIDE ASSOCIATION STUDY OF MODIFIABLE RISK FOR ALZHEIMER'S DISEASE: 269 LOCI ASSOCIATED WITH BRAIN HEALTH
.
European Neuropsychopharmacology
vol.
51
,
e159
-
e159
.
Hone L, Jacobs B, Marshall C, Giovannoni G, Noyce A, Dobson R
(
2021
)
.
Age-specific effects of childhood Body Mass Index on multiple sclerosis risk
.
Yam C, Rog D, Ford H, Murray K, Hughes S, Pearson O, Brex P, Dobson R
(
2021
)
.
UK variance in DMT advice and prescribing in MS and pregnancy: impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelines
.
Multiple Sclerosis and Related Disorders103272
-
103272
.
Kuri A, Jacobs BM, Leddy S, Schmierer K, Turner B, Allen-Philbey K, Stennett A, Giovannoni G et al.
(
2021
)
.
Evaluation of remote assessments for multiple sclerosis in an in-home setting
.
Multiple Sclerosis and Related Disorders
vol.
54
,
Huxford B, Haque T, Joseph A, Simonet C, Gallagher D, Budu C, Dobson R, Noyce A
(
2021
)
.
HbA1c correlates with motor and cognitive outcome scores in patients with Parkinson's disease and type 2 diabetes
.
MOVEMENT DISORDERS
.
vol.
36
,
S452
-
S452
.
Jacobs BM, Noyce AJ, Bestwick J, Belete D, Giovannoni G, Dobson R
(
2021
)
.
Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study
.
Neurology(R) neuroimmunology & neuroinflammation
vol.
8
,
(
4
)
Jacobs BM, Smets I, Giovannoni G, Noyce A, Jokubaitis V, Dobson R
(
2021
)
.
Regarding: Nicotinic acetylcholine receptors α7 and α9 modify tobacco smoke risk for multiple sclerosis
.
Multiple Sclerosis Journal
vol.
27
,
(
8
)
1311
-
1312
.
Dobson R
(
2021
)
.
Differing Impact of DMT on Relapse and Progression: Time to Consider Inflammation and Neuroprotection Separately?
.
Neurology
Leavitt VM, Dobson R, Svennigsson A
(
2021
)
.
Perinatal Depression and Anxiety in Multiple Sclerosis: Treatable Distress
.
Neurology
vol.
96
,
(
23
)
1067
-
1068
.
Garjani A, Hunter R, Law G, Middleton R, Tuite-Dalton KA, Dobson R, Ford DV, Hughes S et al.
(
2021
)
.
Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS Register
.
Multiple Sclerosis Journal
Dobson R, Hellwig K
(
2021
)
.
Use of disease-modifying drugs during pregnancy and breastfeeding
.
Current Opinion in Neurology
vol.
34
,
(
3
)
303
-
311
.
Dobson R, ALLEN-PHILBEY K, Giovannoni G, Baker D, Schmierer K
(
2021
)
.
Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
.
Multiple Sclerosis and Related Disorders
Garjani A, Middleton RM, Hunter R, Tuite-Dalton KA, Coles A, Dobson R, Duddy M, Hughes S et al.
(
2021
)
.
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
.
Multiple Sclerosis and Related Disorders
vol.
52
,
102939
-
102939
.
Taylor TRP, Galloway J, Davies R, Hyrich K, Dobson R
(
2021
)
.
Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis
.
Neurology(R) neuroimmunology & neuroinflammation
vol.
8
,
(
3
)
Jensen MP, Jacobs BM, Dobson R, Bandres-Ciga S, Blauwendraat C, Schrag A, Noyce AJ
(
2021
)
.
Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease
.
Annals of Neurology
vol.
89
,
(
4
)
803
-
812
.
Krysko KM, Bove R, Dobson R, Jokubaitis V, Hellwig K
(
2021
)
.
Treatment of Women with Multiple Sclerosis Planning Pregnancy
.
Current Treatment Options in Neurology
vol.
23
,
(
4
)
Jitlal M, Amirthalingam G, Karania T, Parry E, Neligan A, Dobson R, Noyce A, MARSHALL C
(
2021
)
.
The influence of socioeconomic deprivation on dementia mortality, age at death and quality of diagnosis: a nationwide death records study in England and Wales 2001-2017
.
Journal of Alzheimer's Disease
Dobson R, Fenton N, Hartmann M
(
2021
)
.
Current Review and Next Steps for Artificial intelligence in Multiple Sclerosis risk research
.
Computers in Biology and Medicine
Garjani A, Middleton R, Hunter R, Tuite-Dalton K, Coles A, Dobson R, Duddy M, Hughes S et al.
(
2021
)
.
COVID-19 is associated with multiple sclerosis exacerbations that are prevented by disease modifying therapies
.
Foote I, Jacobs B, Mathlin G, Watson C, Bothongo PLK, Waters S, Dobson R, Noyce A et al.
(
2021
)
.
The Genetic Architecture of Alzheimer’s Disease Risk: A Genomic Structural Equation Modelling Study
.
Thomson A, Dobson R, Baker D, Giovannoni G
(
2021
)
.
Digesting science: Developing educational activities about multiple sclerosis, prevention and treatment to increase the confidence of affected families
.
Multiple Sclerosis and Related Disorders
vol.
47
,
Evangelou N, Garjani A, Dasnair R, Hunter R, Tuite-Dalton KA, Craig EM, Rodgers WJ, Coles A et al.
(
2021
)
.
Self-diagnosed COVID-19 in people with multiple sclerosis: A community-based cohort of the UK MS Register
.
Journal of Neurology, Neurosurgery and Psychiatry
vol.
92
,
(
1
)
107
-
109
.
Bothongo PL, Jitlal M, Parry E, Foote IF, Waters S, Dobson R, Noyce AJ, Bestwick JP et al.
(
2020
)
.
Ethnic and socioeconomic determinants of dementia risk: A nested case‐control study in the population of East London
.
Alzheimer's & Dementia
vol.
16
,
(
S10
)
Garjani A, Hunter R, Nicholas R, Middleton R, Tuite-Dalton K, Coles A, Dobson R, Duddy M et al.
(
2020
)
.
Anxiety affects the general well-being of people with ms during the COVID-19 pandemic more than the infection itself
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
26
,
65
-
65
.
Garjani A, Evangelou N, Das Nair R, Hunter R, Tuite-Dalton K, Coles A, Dobson R, Duddy M et al.
(
2020
)
.
COVID-19 in people with MS: a large community-based study of the UK MS register
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
26
,
46
-
47
.
Taylor T, Luis J, Dobson R, Petrushkin H
(
2020
)
.
Demographics of multiple sclerosis associated uveitis at moorfields eye hospital
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
26
,
484
-
484
.
Taylor T, Galloway J, Adam R, Hyrich K, Dobson R
(
2020
)
.
Demyelinating events following initiation of anti-tnf alpha therapy in the british society for rheumatology biologics registry in rheumatoid arthritis
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
26
,
241
-
241
.
Jacobs B, Noyce A, Bestwick J, Belete D, Giovannoni G, Dobson R
(
2020
)
.
Gene-environment interactions in multiple sclerosis: a uk biobank study
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
26
,
367
-
367
.
Vickaryous N, Jitlal M, Jacobs BM, Middleton R, Chandran S, MacDougall NJJ, Giovannoni G, Dobson R
(
2020
)
.
Remote testing of vitamin D levels across the UK MS population—A case control study
.
PLoS ONE
vol.
15
,
(
12 December
)
Vickaryous N, Garjani A, Jacobs B, Jitlal M, Middleton R, Das Nair R, Tuite-Dalton K, Hunter R et al.
(
2020
)
.
Vitamin D levels in the UK MS population and COVID-19 susceptibility
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
26
,
55
-
55
.
Vickaryous N, Jitlal M, Jacobs BM, Middleton R, Chandran S, MacDougall NJJ, Giovannoni G, Dobson R
(
2020
)
.
Remote testing of vitamin D levels across the UK MS population – a case control study
.
Auger SD, Jacobs BM, Dobson R, Marshall CR, Noyce AJ
(
2020
)
.
Big data, machine learning and artificial intelligence: a neurologist's guide
.
Pract Neurol
vol.
21
,
(
1
)
4
-
11
.
Auger S, Jacobs B, Dobson R, MARSHALL C, Noyce A
(
2020
)
.
Navigating a world of big data, machine learning and artificial intelligence: a neurologist's guide
.
Practical Neurology
Jacobs B, Belete D, Bestwick J, Blauwendraat C, Bandres-Ciga S, Heilbron K, Dobson R, International Parkinson’s Disease Genomics Consortium (IPDGC) et al.
(
2020
)
.
Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank
.
Journal of Neurology, Neurosurgery and Psychiatry
vol.
91
,
1046
-
1054
.
Leddy S, Dobson R
(
2020
)
.
Multiple sclerosis
.
Medicine (United Kingdom)
vol.
48
,
(
9
)
588
-
594
.
Belete D, Jacobs B, Bestwick J, Blauwendraat C, Bandres-Ciga S, Heilbron K, Dobson R, Nalls M et al.
(
2020
)
.
Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank
.
MOVEMENT DISORDERS
.
vol.
35
,
S74
-
S74
.
Dobson R, Giovannoni G, Cuzick J
(
2020
)
.
Estimated and projected burden of multiple sclerosis attributable to smoking and childhood and adolescent high body-mass index: a comparative risk assessment
.
International Journal of Epidemiology
Dobson R
(
2020
)
.
MS, pregnancy and COVID-19
.
Multiple Sclerosis Journal
Jacobs B, Taylor T, Awad A, Baker D, Giovannoni G, Noyce A, Dobson R
(
2020
)
.
Summary-data-based mendelian randomisation prioritises potential druggable targets for Multiple Sclerosis
.
Brain Communications
Taylor TR, Jacobs BM, Giovannoni G, Petrushkin H, Dobson R
(
2020
)
.
Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study
.
Multiple Sclerosis and Related Disorders
vol.
43
,
Peeters LM, Parciak T, Walton C, Geys L, Moreau Y, De Brouwer E, Raimondi D, Pirmani A et al.
(
2020
)
.
COVID-19 in people with multiple sclerosis: A global data sharing initiative
.
Mult Scler1352458520941485
-
1352458520941485
.
Reyes S, Ramsay M, Ladhani S, Amirthalingam G, Singh N, Cores C, Mathews J, Lambourne J et al.
(
2020
)
.
Protecting people with multiple sclerosis through vaccination
.
Practical Neurology
Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R et al.
(
2020
)
.
Sex effects across the lifespan in women with multiple sclerosis
.
Therapeutic Advances in Neurological Disorders
vol.
13
,
Kuri A, Jacobs BM, Vickaryous N, Pakpoor J, Middeldorp J, Giovannoni G, Dobson R
(
2020
)
.
Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom
.
BMC Public Health
vol.
20
,
(
1
)
Dobson R, Jokubaitis V, Giovannoni G
(
2020
)
.
Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis
.
Multiple Sclerosis and Related Disorders
Dobson R, Mowry EM
(
2020
)
.
Breastfeeding may reduce postpartum relapse in some women with multiple sclerosis
.
Neurology
vol.
94
,
(
18
)
769
-
770
.
Leddy S, Jacobs BM, Giovannoni G, Dobson R
(
2020
)
.
To examine the impact of Multiple Sclerosis on bone health and explore mechanisms for this association
.
EUROPEAN JOURNAL OF NEUROLOGY
.
vol.
27
,
981
-
981
.
Leddy S, Jacobs B, Giovannoni G, Dobson R
(
2020
)
.
Bone health, fracture risk, and Multiple Sclerosis: a UK Biobank study
.
NEUROLOGY
.
vol.
94
,
Jacobs B, Giovannoni G, Dobson R
(
2020
)
.
Environmental exposures associated with Multiple Sclerosis: a UK Biobank study
.
NEUROLOGY
.
vol.
94
,
Dobson R, Jitlal M, Marshall CR, Noyce AJ, Robson J, Cuzick J, Giovannoni G
(
2020
)
.
Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk
.
Annals of Neurology
vol.
87
,
(
4
)
599
-
608
.
Dobson R, Jacobs B, Giovannoni G, Cuzick J
(
2020
)
.
Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors
.
Multiple Sclerosis Journal
Jokubaitis VG, Dobson R
(
2020
)
.
Reader response: Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis
.
Neurology
vol.
94
,
(
10
)
455
-
456
.
Jacobs BM, Noyce A, Bestwick J, Belete D, Giovannoni G, Dobson R
(
2020
)
.
Gene-environment interactions in Multiple Sclerosis: a UK Biobank study
.
Jokubaitis V, Dobson R
(
2020
)
.
Family planning is the second most relevant factor for treatment decisions after disease activity
.
Multiple Sclerosis Journal
Jacobs B, Belete D, Bestwick J, Blauwendraat C, Bandres-Ciga S, Heilbron K, Dobson R, Nalls M et al.
(
2020
)
.
Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank
.
Kuri A, Jacobs BM, Vickaryous N, Pakpoor J, Middeldorp J, Giovannoni G, Dobson R
(
2020
)
.
Epidemiology of Epstein-Barr Virus infection and Infectious Mononucleosis in the United Kingdom
.
Jacobs BM, Taylor T, Awad A, Baker D, Giovanonni G, Noyce A, Dobson R
(
2020
)
.
Summary-data-based mendelian randomisation reveals druggable targets for multiple sclerosis
.
Dobson R, Noyce A, Giovannoni G, jacobs B
(
2020
)
.
BMI and low serum vitamin D are causal risk factors for Multiple Sclerosis: a Mendelian Randomisation study
.
Neurology, Neuroimmunology and Neuroinflammation
Jacobs BM, Giovannoni G, Cuzick J, Dobson R
(
2019
)
.
Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors
.
medRxiv19007450
-
19007450
.
Dobson R, Jitlal M, Marshall C, Noyce A, Giovannoni G
(
2019
)
.
Obesity is not associated with MS in a socially and ethnically diverse population
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
25
,
49
-
49
.
Vickaryous N, Jitlal M, Middleton R, Giovannoni G, Dobson R
(
2019
)
.
Vitamin D levels in the UK MS population
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
25
,
449
-
450
.
DOBSON R
(
2019
)
.
Visibility and representation of women in multiple sclerosis research
.
Neurology
Dobson R, Dassan P, Roberts M, Giovannoni G, Nelson-Piercy C, Brex PA
(
2019
)
.
UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines
.
Pract Neurol
Waubant E, Amezcua L, Sicotte N, Hellwig K, Krupp L, Weinstock-Guttman B, Yeh A, Lucas RM et al.
(
2018
)
.
Gender Inequities in the Multiple Sclerosis Community: A Call for Action
.
Annals of Neurology
vol.
84
,
(
6
)
958
-
959
.
Dobson R
(
2018
)
.
Clinical commentary on 'Life-threatening vitamin D intoxication due to intake of ultra-high doses in multiple sclerosis: a note of caution'
.
Mult Scler1352458518807053
-
1352458518807053
.
Dobson R, Giovannoni G
(
2018
)
.
Multiple Sclerosis - a review
.
Eur J Neurol
vol.
26
,
27
-
40
.
Thomson A, Aldam R, Giovannoni G, Dobson R
(
2018
)
.
Making science digestible: the development of educational activities for children with a parent with MS, and the need to better engage families
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
24
,
972
-
972
.
Dobson R, Cock HR, Brex P, Giovannoni G
(
2018
)
.
Vitamin D supplementation
.
Practical Neurology
vol.
18
,
(
1
)
35
-
42
.
Middleton RM, Rodgers WJ, Giovannoni G, Schmierer K, Dobson R, Allen-Philbey K, Patterson A, Akbari A et al.
(
2017
)
.
A Comparison of participant supplied EDSS scores and clinically submitted data via the UK MS Register
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
23
,
153
-
154
.
Dobson R, Kuhle J, Middeldorp J, Giovannoni G
(
2017
)
.
Epstein-Barr-negative MS: a true phenomenon?
.
Neurol Neuroimmunol Neuroinflamm
vol.
4
,
(
2
)
e318
-
e318
.
Dobson R, Ramagopalan S, Topping J, Smith P, Solanky B, Schmierer K, Chard D, Giovannoni G
(
2016
)
.
A Risk Score for Predicting Multiple Sclerosis
.
PLoS One
vol.
11
,
(
11
)
Article
0164992
,
e0164992
-
e0164992
.
Collins CDE, Ivry B, Bowen JD, Cheng EM, Dobson R, Goodin DS, Lechner-Scott J, Kappos L et al.
(
2016
)
.
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools
.
Multiple Sclerosis
vol.
22
,
(
10
)
1349
-
1358
.
Binks S, Dobson R
(
2016
)
.
Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease
.
Curr Osteoporos Rep
vol.
14
,
(
5
)
199
-
210
.
Dobson R, Alvares D
(
2016
)
.
The difficulties with vitamin B<inf>12</inf>
.
Practical Neurology
vol.
16
,
(
4
)
308
-
311
.
Topping J, Dobson R, Lapin S, Maslyanskiy A, Kropshofer H, Leppert D, Giovannoni G, Evdoshenko E
(
2016
)
.
The effects of intrathecal rituximab on biomarkers in multiple sclerosis
.
Multiple Sclerosis and Related Disorders
vol.
6
,
49
-
53
.
Davis AG, Dobson R, Kaninia S, Giovannoni G, Schmierer K
(
2016
)
.
Atraumatic needles for lumbar puncture: Why haven’t neurologists changed?
.
Practical Neurology
vol.
16
,
(
1
)
18
-
22
.
Disanto G, Adiutori R, Dobson R, Martinelli V, Costa GD, Runia T, Evdoshenko E, Thouvenot E et al.
(
2016
)
.
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome
.
Journal of Neurology, Neurosurgery and Psychiatry
vol.
87
,
(
2
)
126
-
129
.
Binks S, Dobson R
(
2015
)
.
Established, new and future disease modifying therapies for MS
.
Progress in Neurology and Psychiatry
vol.
19
,
(
5
)
27
-
35
.
Kuhle J, Gaiottino J, Leppert D, Petzold A, Bestwick JP, Malaspina A, Lu CH, Dobson R et al.
(
2015
)
.
Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome
.
Journal of Neurology, Neurosurgery and Psychiatry
vol.
86
,
(
3
)
273
-
279
.
Kuhle J, Gaiottino J, Leppert D, Petzold A, Bestwick JP, Malaspina A, Lu C-H, Dobson R et al.
(
2015
)
.
Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome
.
J Neurol Neurosurg Psychiatry
vol.
86
,
(
3
)
273
-
279
.
Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick JP, Meier UC et al.
(
2015
)
.
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
.
Multiple Sclerosis Journal
vol.
21
,
(
8
)
1013
-
1024
.
Leddy S, Fowler AJ, Giovanonni G, Dobson R
(
2014
)
.
DEPRESSION IN MS: A SYSTEMATIC REVIEW AND META-ANALYSIS
.
Journal of Neurology Neurosurgery & Psychiatry
.
vol.
85
,
e4
-
e4
.
Cooper R, Doshi A, Harris P, Sivagnanasundaram J, Wells G, Barritt A, Aram J, Giovannoni G et al.
(
2014
)
.
IMMUNOCOMPETENT PML—AN IMMUNOLOGICAL SCOTOMA?
.
Journal of Neurology Neurosurgery & Psychiatry
.
vol.
85
,
e4
-
e4
.
Disanto G, Dobson R, Pakpoor J, Elangovan RI, Adiutori R, Gobbi C, Kuhle J, Giovannoni G
(
2014
)
.
Genetic predictors of multiple sclerosis
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
20
,
253
-
253
.
Disanto G, Dobson R, Pakpoor J, Elangovan RI, Adiutori R, Kuhle J, Giovannoni G
(
2014
)
.
The refinement of genetic predictors of multiple sclerosis
.
PLoS ONE
vol.
9
,
(
5
)
Shribman SE, Torsney K, Noyce AJ, Giovannoni G, Fearnley J, Dobson R
(
2014
)
.
A service development study of the assessment and management of fracture risk in Parkinson's disease
.
MOVEMENT DISORDERS
.
vol.
29
,
S192
-
S192
.
Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ
(
2014
)
.
A systematic review and meta-analysis of fracture risk in Parkinson's disease
.
MOVEMENT DISORDERS
.
vol.
29
,
S551
-
S551
.
Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ
(
2014
)
.
Bone health in Parkinson's disease: A systematic review and meta-analysis
.
MOVEMENT DISORDERS
.
vol.
29
,
S551
-
S551
.
Davis A, Dobson R, Kaninia S, Espasandin M, Berg A, Giovannoni G, Schmierer K
(
2014
)
.
Change practice now! Using atraumatic needles to prevent post lumbar puncture headache
.
European Journal of Neurology
vol.
21
,
(
2
)
305
-
311
.
Dobson R, Rudick RA, Turner B, Schmierer K, Giovannoni G
(
2014
)
.
Assessing treatment response to interferon-beta Is there a role for MRI?
.
NEUROLOGY
vol.
82
,
(
3
)
248
-
254
.
Dobson R, Rudick RA, Turner B, Schmierer K, Giovannoni G
(
2014
)
.
Assessing treatment response to interferon-β :Is there a role for MRI?
.
Neurology
vol.
82
,
(
3
)
248
-
254
.
Shribman S, Torsney KM, Noyce AJ, Giovannoni G, Fearnley J, Dobson R
(
2014
)
.
A service development study of the assessment and management of fracture risk in Parkinson's disease
.
Journal of Neurology
vol.
261
,
(
6
)
1153
-
1159
.
Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ
(
2014
)
.
Bone health in Parkinson's disease: A systematic review and meta-analysis
.
Journal of Neurology, Neurosurgery and Psychiatry
vol.
85
,
(
10
)
1159
-
1166
.
Raffel J, Dobson R, Gafson A, Mattoscio M, Muraro P, Giovannoni G
(
2014
)
.
Multiple sclerosis therapy and Epstein-Barr virus antibody titres
.
Multiple Sclerosis and Related Disorders
vol.
3
,
(
3
)
372
-
374
.
Hadavi S, Baker MD, Dobson R
(
2014
)
.
Sustained-release fampridine in Multiple Sclerosis
.
Multiple Sclerosis and Related Disorders
vol.
3
,
(
1
)
17
-
21
.
Leddy S, Hadavi S, Carren AM, Giovanonni G, Dobson R
(
2013
)
.
A novel internet-based method of capturing outcomes in multiple sclerosis
.
J Neurol Neurosurg Psychiatry
vol.
84
,
(
11
)
Hadavi S, Giovannoni G, Dobson R
(
2013
)
.
A service development audit of fampridine use in ms
.
J Neurol Neurosurg Psychiatry
vol.
84
,
(
11
)
Dobson R, Topping J, Davis A, Thompson E, Giovannoni G
(
2013
)
.
Cerebrospinal fluid and urinary biomarkers in multiple sclerosis
.
Acta Neurologica Scandinavica
vol.
128
,
(
5
)
321
-
327
.
Hadavi S, Shribman S, Nagy A, Acharya S, Fearnley J, Dobson R, Lees A, Giovannoni G et al.
(
2013
)
.
The bradykinesia-akinesia incoordination test: a simple objective test in multiple sclerosis
.
J Neurol Neurosurg Psychiatry
vol.
84
,
(
11
)
Dobson R, McMillan A, Kung K, Thom M, Davis A, Simister R, Giovannoni G, Gnanapavan S
(
2013
)
.
Think outside the box, collapse the box, and take a sharp knife to it!
.
J Neurol Neurosurg Psychiatry
vol.
84
,
(
11
)
Dobson R, Topping J, Ramagopalan S, Giovannoni G
(
2013
)
.
Towards an endophenotype in multiple sclerosis
.
J Neurol Neurosurg Psychiatry
vol.
84
,
(
11
)
Leddy S, Hadavi S, McCarren A, Giovannoni G, Dobson R
(
2013
)
.
A novel internet-based method of capturing outcomes in multiple sclerosis
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
19
,
357
-
358
.
Dobson R, Giovannoni G
(
2013
)
.
Bone health in multiple sclerosis: should we be doing more?
.
Neurodegenerative Disease Management
vol.
3
,
(
5
)
401
-
403
.
Kuhle J, Dobson R, Bestwick JP, Topping J, Dalla Costa G, Khademi M, Sombekke M, Killestein J et al.
(
2013
)
.
Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
19
,
33
-
34
.
James E, Dobson R, Kuhle J, Baker D, Giovannoni G, Ramagopalan SV
(
2013
)
.
The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis
.
Mult Scler
vol.
19
,
(
12
)
1571
-
1579
.
Leddy S, Hadavi S, McCarren A, Giovannoni G, Dobson R
(
2013
)
.
Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis
.
J Neurol
vol.
260
,
(
10
)
2505
-
2510
.
Gaiottino J, Norgren N, Dobson R, Topping J, Nissim A, Malaspina A, Bestwick JP, Monsch AU et al.
(
2013
)
.
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
.
PLoS ONE
vol.
8
,
(
9
)
Dobson R, Ramagopalan S, Davis A, Giovannoni G
(
2013
)
.
Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude
.
J Neurol Neurosurg Psychiatry
vol.
84
,
(
8
)
909
-
914
.
Dobson R, Giovannoni G
(
2013
)
.
Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis
.
J Neurol
vol.
260
,
(
5
)
1272
-
1285
.
Dobson R, Yarnall A, Noyce AJ, Giovannoni G
(
2013
)
.
Bone health in chronic neurological diseases: a focus on Multiple sclerosis and Parkinsonian syndromes
.
Pract Neurol
vol.
13
,
(
2
)
70
-
79
.
Pakpoor J, Handel AE, Giovannoni G, Dobson R, Ramagopalan SV
(
2013
)
.
Correction: Meta-analysis of the relationship between multiple sclerosis and migraine (PLoS ONE)
.
PLoS ONE
vol.
8
,
(
4
)
Dobson R, Giovannoni G, Ramagopalan S
(
2013
)
.
The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude
.
J Neurol Neurosurg Psychiatry
vol.
84
,
(
4
)
427
-
432
.
Dobson R, Leddy SG, Gangadharan S, Giovannoni G
(
2013
)
.
Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems
.
BMJ Open
vol.
3
,
(
3
)
Dobson R, Ramagopalan SV, Giovannoni G
(
2013
)
.
Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?
.
Expert Rev Neurother
vol.
13
,
(
3
)
235
-
237
.
Pakpoor J, Disanto G, Gerber JE, Dobson R, Meier UC, Giovannoni G, Ramagopalan SV
(
2013
)
.
The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis
.
Mult Scler
vol.
19
,
(
2
)
162
-
166
.
Dobson R, Ramagopalan S, Davis A, Giovannoni G
(
2013
)
.
Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: A meta-analysis of prevalence, prognosis and effect of latitude
.
Journal of Neurology, Neurosurgery and Psychiatry
vol.
84
,
(
8
)
909
-
914
.
Dobson R, Topping J, Giovannoni G
(
2013
)
.
Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers
.
J Med Virol
vol.
85
,
(
1
)
128
-
131
.
Evdoshenko E, Maslyanskiy A, Lapin S, Zaslavsky L, Dobson R, Totolian A, Skoromets A, Bar-Or A
(
2013
)
.
Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone
.
ISRN Neurol
vol.
2013
,
Dobson R, Giovannoni G, Ramagopalan S
(
2013
)
.
The month of birth effect in multiple sclerosis: Systematic review, meta-analysis and effect of latitude
.
Journal of Neurology, Neurosurgery and Psychiatry
vol.
84
,
(
4
)
427
-
432
.
Dobson R, Ramagopalan S, Giovannoni G
(
2012
)
.
Bone health and multiple sclerosis
.
Mult Scler
vol.
18
,
(
11
)
1522
-
1528
.
Dobson R, Rudick RA, Giovannoni G
(
2012
)
.
CAN WE RELIABLY USE MRI TO MONITOR TREATMENT RESPONSE IN PATIENTS ON INTERFERON beta: A SYSTEMATIC REVIEW AND META-ANALYSIS
.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
.
vol.
83
,
Dobson R, Ramagopalan S, Giovannoni G
(
2012
)
.
Risk of fractures in patients with multiple sclerosis: A populationbased cohort study
.
Neurology
vol.
79
,
(
18
)
1934
-
1935
.
Davis A, Dobson R, Espasandin M, Giovannoni G, Schmierer K
(
2012
)
.
Cerebrospinal fluid biomarkers as outcome measures in clinical trials of MS: The significance of post lumbar puncture headaches
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
18
,
237
-
238
.
Dobson R, Ramagopalan S, Giovannoni G
(
2012
)
.
Osteoporosis and fracture risk in multiple sclerosis
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
18
,
243
-
244
.
Topping J, Evdoshenko E, Dobson R, Lapin S, Maslyanskiy A, Giovannoni G
(
2012
)
.
The effects of intrathecal rituximab on biomarkers in MS
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
18
,
268
-
268
.
Dobson R, Topping J, Davis A, Giovannoni G
(
2012
)
.
Urinary and CSF biomarkers in multiple sclerosis
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
18
,
502
-
503
.
Pakpoor J, Handel AE, Giovannoni G, Dobson R, Ramagopalan SV
(
2012
)
.
Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine
.
PLoS ONE
vol.
7
,
(
9
)
Dobson R, Ramagopalan S, Giovannoni G
(
2012
)
.
The effect of gender in clinically isolated syndrome (CIS): a meta-analysis
.
Mult Scler
vol.
18
,
(
5
)
600
-
604
.
Dobson R
(
2012
)
.
Urine: An under-studied source of biomarkers in multiple sclerosis?
.
Multiple Sclerosis and Related Disorders
vol.
1
,
(
2
)
76
-
80
.
Disanto G, Sandve GK, Berlanga-Taylor AJ, Morahan JM, Dobson R, Giovannoni G, Ramagopalan SV
(
2012
)
.
Genomic Regions Associated with Multiple Sclerosis Are Active in B Cells
.
PLOS ONE
vol.
7
,
(
3
)
Article
ARTN e32281
,
Dobson R, Meier UC, Schmierer K, Giovannoni G
(
2012
)
.
DO SIBLINGS OF PEOPLE WITH MULTIPLE SCLEROSIS (MS) HAVE MARKERS OF MS RISK?
.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
.
vol.
83
,
Raffel J, Dobson R, Giovannoni G
(
2012
)
.
THE EFFECT OF NATALIZUMAB AND INTERFERON-beta ON URINARY FREE LIGHT CHAINS AND ANTI-EBV NUCLEAR ANTIGEN-1 ANTIBODIES IN RELAPSING REMITTING MULTIPLE SCLEROSIS
.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
.
vol.
83
,
Dobson R, Giovannoni G
(
2012
)
.
WHY CAN'T I WIN ANY MORE?
.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
.
vol.
83
,
Dobson R, Meier UC, Marta M, Ramagopalan S, Giovannoni G
(
2011
)
.
Vitamin D deficiency - do we follow our own advice?
.
CLINICAL MEDICINE
vol.
11
,
(
6
)
521
-
523
.
Dobson R, Meier UC, Schmierer K, Giovannoni G
(
2011
)
.
Do siblings have markers of multiple sclerosis risk?
.
MULTIPLE SCLEROSIS JOURNAL
vol.
17
,
S86
-
S86
.
Dobson R, Lawden M
(
2011
)
.
Melanoma associated retinopathy and how to understand the electroretinogram
.
Pract Neurol
vol.
11
,
(
4
)
234
-
239
.
Maghzi A-H, Marta M, Bosca I, Etemadifar M, Dobson R, Maggiore C, Giovannoni G, Meier U-C
(
2011
)
.
Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?
.
Pathophysiology
vol.
18
,
(
1
)
13
-
20
.
Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, Ramagopalan SV
(
2011
)
.
Smoking and Multiple Sclerosis: An Updated Meta-Analysis
.
PLOS ONE
vol.
6
,
(
1
)
Article
e16149
,
Meier UC, Giovannoni G
(
2011
)
.
More to come: humoral immune responses in MS
.
Journal of Neuroimmunology
vol.
240-241
,
13
-
21
.
Dobson R, Feldmann M, Thompson AJ, Giovannoni G, Miller DH, Thompson EJ, Palmer HE, Miller RF
(
2010
)
.
INCREASED URINARY FREE IMMUNOGLOBULIN LIGHT CHAIN EXCRETION IN PATIENTS WITH MULTIPLE SCLEROSIS
.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
.
vol.
81
,
E57
-
E57
.
Dobson R, Lawden M
(
2010
)
.
CP1 Darkness visible
.
Journal of Neurology Neurosurgery & Psychiatry
vol.
81
,
(
11
)
Ramagopalan SV, Dobson R, Meier UC, Giovannoni G
(
2010
)
.
Multiple sclerosis: risk factors, prodromes, and potential causal pathways
.
Lancet Neurol
vol.
9
,
(
7
)
727
-
739
.
Dobson R, Miller RF, Palmer HE, Feldmann M, Thompson EJ, Thompson AJ, Miller DH, Giovannoni G
(
2010
)
.
Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis
.
J Neuroimmunol
vol.
220
,
(
1-2
)
99
-
103
.